electroCore, Inc.
NASDAQ: ECOR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Thomas J. Errico
- Employees
- 73
- Headquarters
- Rockaway, United States
- IPO year
- 2018
- Market cap
- $62.8M
- Website
- https://www.electrocore.com
Loading ECOR…
Loading profile data…Frequently asked questions about ECOR
What does electroCore, Inc. (ECOR) do?
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with...
Where does ECOR trade?
electroCore, Inc. (ECOR) trades on the NASDAQ Capital Market.
What sector is ECOR in?
electroCore, Inc. (ECOR) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of electroCore, Inc.?
Thomas J. Errico is the chief executive officer of electroCore, Inc. (ECOR).
Where is electroCore, Inc. headquartered?
electroCore, Inc. is headquartered in United States.
Does ECOR pay a dividend?
electroCore, Inc. (ECOR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ECOR go public?
electroCore, Inc. (ECOR) completed its initial public offering in 2018.